Medical Developments International Ltd
MVP
Company Profile
Business description
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
Contact
4 Caribbean Drive
ScoresbyVIC3179
AUST: +61 395471888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
68
Medical Developments International Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,044.20 | 62.10 | -0.68% |
| CAC 40 | 7,872.02 | 41.91 | 0.54% |
| DAX 40 | 23,611.33 | 84.28 | 0.36% |
| Dow JONES (US) | 46,292.78 | 88.76 | -0.19% |
| FTSE 100 | 9,223.32 | 3.36 | -0.04% |
| HKSE | 26,386.63 | 227.51 | 0.87% |
| NASDAQ | 22,573.47 | 215.50 | -0.95% |
| Nikkei 225 | 45,528.39 | 34.73 | 0.08% |
| NZX 50 Index | 13,181.31 | 44.77 | 0.34% |
| S&P 500 | 6,656.92 | 36.83 | -0.55% |
| S&P/ASX 200 | 8,751.00 | 64.00 | -0.73% |
| SSE Composite Index | 3,841.01 | 19.18 | 0.50% |